4
Changes in Ownership
Bicara Therapeutics Inc. Filed Acc 0001470831-26-000701
President and COO sold 28,750 shares at an average $28.98 ($833,129)
- President and COO acquired 18,750 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Cohlhepp Ryan President and COO | 2026-07-08 | Option exercise 10b5-1 | +18,750 | $3.79 | $71,059 | 210,391 | D: show line 1 in the form |
| Cohlhepp Ryan President and COO | 2026-07-08 | Sale 10b5-1 | −22,833 | $28.76 | $656,652 | 187,558 | D: show line 2 in the form |
| Cohlhepp Ryan President and COO | 2026-07-08 | Sale 10b5-1 | −4,306 | $29.80 | $128,302 | 183,252 | D: show line 3 in the form |
| Cohlhepp Ryan President and COO | 2026-07-08 | Sale 10b5-1 | −1,075 | $30.35 | $32,632 | 182,177 | D: show line 4 in the form |
| Cohlhepp Ryan President and COO | 2026-07-09 | Sale 10b5-1 | −536 | $29.00 | $15,544 | 181,641 | D: show line 5 in the form |
| Open-market sales · 28,750 sh · avg $28.98 · $833,129 | |||||||
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Cohlhepp Ryan President and COO | 2026-07-08 | Option exercise · Stock Option (Right to Buy) 10b5-1 | −18,750 | 70,502 | D: show line 6 in the form |
Loading xslF345X06/wk-form4_1783714248.xml…